XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Investments and Fair Value Measurements
3 Months Ended
Mar. 31, 2020
Investments and Fair Value Measurements  
Investments and Fair Value Measurements

5. Investments and Fair Value Measurements

Available-for-Sale Securities

The estimated fair value of marketable securities is based on quoted market prices for these or similar investments obtained from a commercial pricing service. The fair market value of marketable securities classified within Level 1 is based on quoted prices for identical instruments in active markets. The fair value of marketable securities classified within Level 2 is based on quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in

markets that are not active; or model-driven valuations whose inputs are observable or whose significant value drivers are observable. Observable inputs may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications.

Available-for-sale securities are summarized below:

March 31, 2020

    

    

    

Gross

    

Gross

    

Amortized

Unrealized

Unrealized

Estimated

(In thousands)

Cost

Gains

Losses

Fair Value

US government securities

Level 1

$

79,855

$

490

$

$

80,345

US government agency securities

Level 2

 

34,935

17

 

34,952

Corporate notes

Level 2

 

2,617

(2)

 

2,615

Commercial paper

Level 2

114,603

48

(39)

114,612

Marketable securities

232,010

555

(41)

232,524

Money market funds

Level 1

200,579

200,579

Total

$

432,589

$

555

$

(41)

$

433,103

December 31, 2019

    

    

    

Gross

    

Gross

    

Amortized

Unrealized

Unrealized

Estimated

(In thousands)

Cost

Gains

Losses

Fair Value

US government securities

Level 1

$

100,746

$

108

$

$

100,854

Corporate notes

Level 2

 

25,466

 

9

 

(1)

 

25,474

Commercial paper

Level 2

112,066

31

(2)

112,095

Marketable securities

238,278

148

(3)

238,423

Money market funds

Level 1

35,736

35,736

Total

$

274,014

$

148

$

(3)

$

274,159

As of March 31, 2020, all of the available-for-sale securities had contractual maturities within 13 months and the weighted-average maturity of marketable securities was approximately 2 months. There have been no material changes to the Company’s valuation techniques during the three months ended March 31, 2020.

Available-for-sale debt securities with unrealized losses are summarized below:

March 31, 2020

Less than 12 Months

Greater than 12 Months

Total

    

    

Gross

    

Gross

    

Gross

Estimated

Unrealized

Estimated

Unrealized

Estimated

Unrealized

(In thousands)

Fair Value

Losses

Fair Value

Losses

Fair Value

Losses

Corporate notes

$

2,615

$

(2)

$

$

2,615

$

(2)

Commercial paper

44,606

(39)

44,606

(39)

Total

$

47,221

$

(41)

$

$

$

47,221

$

(41)

December 31, 2019

Less than 12 Months

Greater than 12 Months

Total

    

    

Gross

    

Gross

    

Gross

Estimated

Unrealized

Estimated

Unrealized

Estimated

Unrealized

(In thousands)

Fair Value

Losses

Fair Value

Losses

Fair Value

Losses

Corporate notes

$

5,507

$

(1)

$

$

$

5,507

$

(1)

Commercial paper

28,137

(2)

28,137

(2)

Total

$

33,644

$

(3)

$

$

$

33,644

$

(3)

The Company invests primarily in high credit quality and short-term maturity debt securities with the intent to hold such securities until maturity at par value. The Company does not intend to sell the investments that are currently in an unrealized loss position, and it is unlikely that it will be required to sell the investments before recovery of their amortized

cost basis, which may be maturity. The Company reviewed its available-for-sale debt securities and determined that there were no credit-related losses to be recognized as of March 31, 2020.

As of March 31, 2020, the Company’s accumulated other comprehensive income (loss) on its condensed consolidated balance sheets consisted of net unrealized gains or losses on available-for-sale investments. During the three months ended March 31, 2020, the Company sold marketable securities for total proceeds of $14.9 million and recognized a minimal net realized gain from the sales based on the specific identification method. The Company did not sell any of its marketable securities for the three months ended March 31, 2019.